Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ARVN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
31 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 2
199 filers reported a long position in ARVN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $63.2M | 7.6M | +11.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $34.3M | 4.1M | +6% |
| D. E. Shaw & Co., Inc. | $29M | 3.5M | -3.9% |
| PFIZER INC | $27.7M | 3.5M | Unchanged |
| ARMISTICE CAPITAL, LLC | $23.2M | 2.8M | +41.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $22.6M | 2.7M | +0.9% |
| TWO SIGMA INVESTMENTS, LP | $21.4M | 2.6M | +40.5% |
| STATE STREET CORP | $18.3M | 2.2M | +20.1% |
| Nextech Invest Ltd. | $17.1M | 1.1M | +108.1% |
| GEODE CAPITAL MANAGEMENT, LLC | $13.9M | 1.7M | +7.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.